EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7
-
Hamid Sedighian Rad
,
Seyed-Latif Mousavi
,
Iraj Rasooli
,
Jafar Amani
,
Moohamad-Reza Jalali-Nadooshan
Abstract
Background and Objective: Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is an important enteric pathogen in human causing bloody or nonbloody diarrhea, which may be complicated by hemolytic uremic syndrome (HUS). Cattle are an important reservoir of EHEC. This research aims at vaccination with a divalent chimer protein composed of EspA 120 and Intimin 282 and its preventive effect of EHEC O157 colonization in mice rectal epithelium.
Materials and Methods: A divalent recombinant EspA-Intimin (EI) protein containing EspA 120 and Intimin 280 attached with a linker was amplified from a trivalent construct and cloned in pET-28a (+) vector. The immunization was conducted in mice after expression and purification of the recombinant EI (rEI).
Results: Mice subcutaneously immunized with rEI, elicited significant rEI specific serum IgG antibodies and showed significantly decreased E.coli O157:H7 shedding compared to the control group.
Conclusion: The chimeric recombinant protein induced strong humoral response as well as protection against oral challenges with live E.coli O157:H7.
Locking M, O′ Brien S, Reilly W, Wright E, Campbell D, Coia J, et al. Risk factors for sporadic cases of Escherichia coli O157 infection: the importance of contact with animal excreta. Epidemiol Infect 2001;127: 215-220.
Stevens MP, van Diemen PM, Dziva F, Jones PW, Wallis TS. Options for the control of enterohaemorrhagic Escherichia coli in ruminants. Microbiology 2002;148: 3767.
Schlundt J, Toyofuku H, Jansen J, Herbst S. Emerging food-borne zoonoses. Rev Sci Tech OIE 2004; 23:513-534.
DeVinney R, Stein M, Reinscheid D, Abe A, Ruschkowski S, Finlay BB. Enterohemorrhagic Escherichia coli O157: H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect Immun 1999; 67: 2389.
Dean P, Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol microbiol 2004; 54: 665-75.
Roe A, Hoey D, Gally D. Regulation, secretion and activity of type III-secreted proteins of enterohaemorrhagic Escherichia coli 0157. Biochem Soc Trans 2003; 31: 98-103.
Amani J, Mousavi SL, Rafati S, Salmanian AH.Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coliO157: H7 in mice. Plant Sci 2011; 180: 620-7.
Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. MolMicrobiol 1998; 30: 911-921.
Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997; 91: 511-520.
Garmendia J, Frankel G, Crepin VF. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 2005; 73: 2573.
La Ragione RM, Patel S, Maddison B, Woodward MJ, Best A, Whitelam GC, et al. Recombinant anti-EspA antibodies block Escherichia coli O157: H7-induced attaching and effacing lesions in vitro. Microbes Infect 2006; 8: 426-433.
Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 2005; 73: 18-29.
Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun 2000; 68: 64.
Nataro JP, Kaper JB. Diarrheagenic escherichia coli.Clin Microbiol Rev 1998; 11: 142.
Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O′ Brien AD. Vaccination of pregnant dams with intiminO157 protects suckling piglets from Escherichia coli O157: H7 infection. Infect Immun 2002; 70: 2414.
Judge NA, Mason HS, O′ Brien AD. Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157: H7 shedding in feces. Infect Immun 2004; 72: 168-175.
McNeilly TN, Mitchell MC, Rosser T, McAteer S, Low JC, Smith DGE, et al. Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157: H7 following oral challenge. Vaccine 2010; 28:1422-1428.
Amani J, Salmanian AH, Rafati S, Mousavi SL.Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157: H7. Vaccine 2010; 28: 6923-6929.
Amani J, Mousavi SL, Rafati S, Salmanian AH. In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications. Theor Biol Med Model 2009; 6: 28.
Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, et al. Decreased shedding of Escherichia coli O157: H7 by cattle following vaccination with type III secreted proteins. Vaccine 2004; 22: 362-369.
Babiuk S, Asper DJ, Rogan D, Mutwiri GK, Potter AA.
Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157: H7 in mice. Microb Pathog 2008; 45: 7-11.
Mundy R, Schuller S, Girard F, Fairbrother JM, Phillips AD, Frankel G. Functional studies of intimin in vivo and ex vivo: implications for host specificity and tissue tropism. Microbiology 2007; 153: 959-967.
Zhang X, He K, Lu W, Zhao P, Luan X, Wen L, et al. Subcutaneous and intranasal immunization with Stx2B- Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157: H7 in mice. Vaccine 2011; 29:3923-3929.
Van Diemen P, Dziva F, Abu-Median A, Wallis T, Van Den Bosch H, Dougan G, et al. Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157: H7 or O26: H. Vet Immunol Immunopathol 2007;116: 47-58.
Dziva F, Vlisidou I, Crepin VF, Wallis TS, Frankel G, Stevens MP. Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157: H7, induces antigen-specific humoral responses but does not confer protection against intestinal colonisation. Vet Microbiol 2007; 123: 254-261.
Vilte DA, Larzabal M, Garbaccio S, Gammella M, Rabinovitz BC, Elizondo AM, et al. Reduced faecal shedding of Escherichia coli O157: H7 in cattle following systemic vaccination with [gamma]-intimin C280 and EspB proteins. Vaccine 2011; 29: 3962-3968.
Yekta MA, Goddeeris B, Vanrompay D, Cox E.Immunization of sheep with a combination of intimin [gamma]; EspA and EspB decreases Escherichia coli O157: H7 shedding. Vet Immunol Immunopathol 2010;140: 42-46.
Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T.Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein eng 2001; 14:529-532.
Kuhne SA, Hawes WS, La Ragione RM, Woodward MJ, Whitelam GC, Gough KC. Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157: H7. J Clin Microbiol 2004; 42: 2966-2976.
Fan H, Wang L, Luo J, Long B. Protection against Escherichia coli O157: H7 challenge by immunization of mice with purified Tir proteins. Mol Biol Rep 2011;39: 1-9.
| Files | ||
| Issue | Vol 5 No 3 (2013) | |
| Section | Articles | |
| Keywords | ||
| Chimeric vaccine Enterohemorrhagic Escherichia coli EspA Intimin | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
